Home › Funds › Citadel Advisors › IPA
Citadel Advisors position in IPA
IMMUNOPRECISE ANTIBODIES LTD
Latest position (Q2 2025)59.50K sh
Reported value held$63.07K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 173.70K | $1.08M | New |
| Q4 2021 | 177.37K | $951.00K | Add |
| Q1 2022 | 318.50K | $1.64M | Add |
| Q2 2022 | 394.66K | $1.52M | Add |
| Q3 2022 | 325.66K | $1.30M | Reduce |
| Q4 2022 | 327.72K | $1.74M | Add |
| Q1 2023 | 381.61K | $1.06M | Add |
| Q2 2023 | 276.68K | $818.98K | Reduce |
| Q3 2023 | 241.98K | $442.82K | Reduce |
| Q4 2023 | 302.33K | $516.99K | Add |
| Q1 2024 | 26.60K | $40.43K | Reduce |
| Q2 2024 | 26.08K | $26.34K | Reduce |
| Q1 2025 | 27.20K | $10.24K | New |
| Q2 2025 | 59.50K | $63.07K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.